FDA Panel: Argus II Artificial Retina’s Benefits Outweigh Risks
This article was originally published in The Gray Sheet
Executive Summary
Second Sight Medical Products gains FDA panel endorsement for humanitarian device exemption approval of Argus II, which would be the first artificial retina available to restore vision to the blind.
You may also be interested in...
Six Devices, Diagnostics Among Cleveland Clinic’s Top 10 Innovations For 2014
At its October Medical Innovation Summit, the Cleveland Clinic unveiled six device and diagnostics products that were selected for inclusion in its list of top 10 innovations for 2014.
Six Devices, Diagnostics Among Cleveland Clinic’s Top 10 Innovations
At its 2013 Innovation Summit, the Cleveland Clinic unveiled six devices and diagnostics among its top 10 innovations.
Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant
Cook Medical’s Zilver PTX stent and Second Sight Medical Products’ Argus II retinal prosthesis system will enjoy new-technology add-on payments in 2014 under CMS’ hospital inpatient prospective payment system final rule.